Protective effects of Alamandine against doxorubicin-induced liver injury in rats

Alamandine effectively mitigates DOX-induced hepatotoxicity, demonstrating its therapeutic potential as an adjunctive agent in chemotherapy through its antioxidant and anti-inflammatory mechanisms.

Authors

Institutions

Publication Details

Journal
BMC Pharmacology and Toxicology
Published
2025-05-03
DOI
https://doi.org/10.1186/s40360-025-00932-0
Citations
3
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
4.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protective effects of Alamandine against doxorubicin-induced liver injury in rats

Maryam Hekmat, Ava Soltani Hekmat, Kazem Javanmardi, Sepehr Ramezanipour
3 citations
BMC Pharmacology and Toxicology
Chemotherapy-induced cardiotoxicity and mitigation
4.16
article

Protective effects of Alamandine against doxorubicin-induced liver injury in rats

Maryam Hekmat, Ava Soltani Hekmat, Kazem Javanmardi, Sepehr Ramezanipour
article en
3 citations

Abstract

Alamandine effectively mitigates DOX-induced hepatotoxicity, demonstrating its therapeutic potential as an adjunctive agent in chemotherapy through its antioxidant and anti-inflammatory mechanisms.

BMC Pharmacology and ToxicologyVol. 26(1)
Shiraz University of Medical Sciences (IR), Fasa University of Medical Sciences (IR)
Fasa University of Medical Sciences
Good health and well-being
Openalex Percentile: Top 6%
Chemotherapy-induced cardiotoxicity and mitigation
4.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.